Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -16.04%325.77M | -8.58%1.35B | -7.93%306.71M | -11.33%308.25M | -15.72%348.97M | 1.06%388.01M | 9.21%1.48B | 11.50%333.11M | 26.05%347.63M | 2.89%414.08M |
| Cost of revenue | -14.80%259.5M | -8.32%1.06B | -10.25%241.86M | -11.60%245.6M | -15.57%266.95M | 4.45%304.57M | 15.62%1.16B | 9.87%269.47M | 30.03%277.82M | 15.90%316.18M |
| Gross profit | -20.58%66.27M | -9.50%292.96M | 1.91%64.86M | -10.25%62.65M | -16.23%82.01M | -9.65%83.44M | -8.81%323.7M | 18.96%63.64M | 12.34%69.81M | -24.49%97.9M |
| Operating expense | -5.91%22.83M | 77.01%138.46M | -11.86%25.07M | 122.33%20.29M | -83.57%3.88M | 41.15%24.26M | 51.60%78.22M | 1,142.74%28.45M | -39.41%9.12M | -43.28%23.61M |
| Selling and administrative expenses | -5.72%24.33M | 57.88%146.25M | -11.86%25.07M | 8.66%23.37M | 31.70%33.85M | 35.17%25.81M | 22.20%92.63M | 107.05%28.45M | -6.00%21.51M | -41.22%25.7M |
| -General and administrative expense | -5.72%24.33M | 57.88%146.25M | -11.86%25.07M | 8.66%23.37M | 31.70%33.85M | 35.17%25.81M | 22.20%92.63M | 107.05%28.45M | -6.00%21.51M | -41.22%25.7M |
| Total other operating income | -2.78%1.5M | -45.94%7.79M | ---- | -75.09%3.08M | 1,332.74%29.97M | -18.80%1.55M | -40.47%14.41M | -76.98%3.79M | 58.33%12.38M | -0.29%2.09M |
| Operating profit | -26.59%43.45M | -37.06%154.51M | 13.03%39.79M | -30.18%42.37M | 5.18%78.13M | -21.26%59.18M | -19.08%245.49M | -37.40%35.2M | 28.89%60.69M | -15.60%74.29M |
| Net non-operating interest income (expenses) | -20.56%14.29M | 1.65%65.82M | -2.30%17.47M | -7.58%14.88M | -2.73%15.48M | 21.10%17.99M | 26.61%64.75M | 12.52%17.88M | 12.84%16.1M | 25.47%15.91M |
| Non-operating interest income | -20.24%14.67M | 1.57%67.74M | -2.84%18.11M | -7.18%15.38M | -2.37%15.86M | 20.66%18.39M | 26.01%66.69M | 11.50%18.64M | 13.76%16.57M | 25.11%16.24M |
| Non-operating interest expense | -5.56%374K | -1.18%1.92M | -15.45%646K | 6.60%501K | 15.24%378K | 3.66%396K | 8.79%1.94M | -8.06%764K | 57.72%470K | 9.70%328K |
| Net investment income | 93.16%-3.64M | -1,863.95%-42.44M | -230.04%-15.14M | -53.28M | -2.16M | -4.59M | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | -113.75%-174K | 0 | 0 | 126.65%129K | |
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -28.33%7.79M | -27.04%3.46M | 10.87M | 4.74M | ||||||
| Income before tax | 126.37%54.1M | -28.94%220.32M | -14.39%45.57M | -25.45%57.25M | 3.63%93.61M | -73.36%23.9M | -12.85%310.06M | -26.70%53.23M | 24.06%76.78M | -9.86%90.33M |
| Income tax | 101.72%3.75M | -28.20%7.18M | -280.70%-3.93M | 27.41%3.71M | 48.50%5.54M | -57.68%1.86M | -67.50%10M | -123.57%-1.03M | -37.25%2.91M | -47.20%3.73M |
| Net income | 128.44%50.35M | -28.97%213.15M | -8.78%49.5M | -27.53%53.54M | 1.70%88.07M | -74.17%22.04M | -7.68%300.06M | -20.49%54.26M | 29.02%73.88M | -7.03%86.6M |
| Net income continuous operations | 128.44%50.35M | -28.97%213.15M | -8.78%49.5M | -27.53%53.54M | 1.70%88.07M | -74.17%22.04M | -7.68%300.06M | -20.49%54.26M | 29.02%73.88M | -7.03%86.6M |
| Noncontrolling interests | 44.71%-1.15M | -4,173.28%-5.6M | 176.89%326K | -1,384.77%-1.94M | -811.00%-1.9M | -692.59%-2.08M | -108.79%-131K | -122.03%-424K | 248.04%151K | 54.57%-209K |
| Net income attributable to the company | 113.51%51.5M | -27.13%218.75M | -10.08%49.17M | -24.75%55.48M | 3.65%89.98M | -71.62%24.12M | -7.21%300.19M | -17.54%54.68M | 28.52%73.72M | -7.26%86.81M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 113.51%51.5M | -27.13%218.75M | -10.08%49.17M | -24.75%55.48M | 3.65%89.98M | -71.62%24.12M | -7.21%300.19M | -17.54%54.68M | 28.52%73.72M | -7.26%86.81M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 112.50%0.0136 | -27.84%0.0578 | -10.34%0.013 | -25.89%0.0146 | 2.59%0.0238 | -71.81%0.0064 | -7.72%0.0801 | -18.54%0.0145 | 27.92%0.0197 | -7.57%0.0232 |
| Diluted earnings per share | 112.50%0.0136 | -27.69%0.0577 | -10.34%0.013 | -25.51%0.0146 | 2.60%0.0237 | -71.81%0.0064 | -8.06%0.0798 | -18.54%0.0145 | 27.27%0.0196 | -7.97%0.0231 |
| Dividend per share | -14.29%0.012 | -31.33%0.057 | -31.58%0.013 | -9.09%0.02 | -54.55%0.01 | -30.00%0.014 | -1.19%0.083 | 35.71%0.019 | 0.00%0.022 | -15.38%0.022 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.